jakhals schreef op 10 december 2019 16:57:
DHSC issues supply disruption alert for Berinert
By Lakshmi PS -
December 9, 2019
Healthcare professionals in secondary or specialist healthcare services are asked to ensure that no new long-term patients are started on Berinert
The Department of Health and Social Care (DHSC) has issued a supply disruption alert for Berinert (Human C1 Esterase inhibitor) 500IU powder and solvent for solution for injection.
The product, manufactured by CSL Behring UK, and other plasma-derived products are facing a global supply constrains for the last 12 years, which is expected to continue well into 2020.
Only limited stock remains in the supply, the DHSC warned.
Healthcare professionals in secondary or specialist healthcare services are asked to ensure that no new long-term patients are started on Berinert and reserve the available stock for patients who require ongoing treatment.